nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—IL6-mediated signaling events—CRP—psoriasis	0.0065	0.148	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—TYK2—psoriasis	0.00486	0.111	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—CP—psoriasis	0.0042	0.0957	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—JUN—psoriasis	0.00393	0.0895	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—STAT3—psoriasis	0.0034	0.0775	CbGpPWpGaD
Alendronate—FDPS—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.0034	0.0774	CbGpPWpGaD
Alendronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00271	0.0618	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—psoriasis	0.00238	0.0541	CbGpPWpGaD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—psoriasis	0.00216	0.0491	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—ITGAL—psoriasis	0.00209	0.0475	CbGpPWpGaD
Alendronate—Constipation—Mycophenolic acid—psoriasis	0.000947	0.000991	CcSEcCtD
Alendronate—Chest pain—Cyclosporine—psoriasis	0.000935	0.000978	CcSEcCtD
Alendronate—Myalgia—Cyclosporine—psoriasis	0.000935	0.000978	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisolone—psoriasis	0.000927	0.00097	CcSEcCtD
Alendronate—Discomfort—Cyclosporine—psoriasis	0.000924	0.000966	CcSEcCtD
Alendronate—Erythema—Triamcinolone—psoriasis	0.000919	0.000961	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PPARG—psoriasis	0.000914	0.0208	CbGpPWpGaD
Alendronate—Angioedema—Prednisolone—psoriasis	0.000913	0.000955	CcSEcCtD
Alendronate—Feeling abnormal—Mycophenolic acid—psoriasis	0.000913	0.000955	CcSEcCtD
Alendronate—Myalgia—Mycophenolate mofetil—psoriasis	0.000912	0.000954	CcSEcCtD
Alendronate—Chest pain—Mycophenolate mofetil—psoriasis	0.000912	0.000954	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000908	0.000949	CcSEcCtD
Alendronate—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000906	0.000948	CcSEcCtD
Alendronate—Ill-defined disorder—Hydrocortisone—psoriasis	0.000906	0.000947	CcSEcCtD
Alendronate—Diarrhoea—Hydroxyurea—psoriasis	0.000905	0.000947	CcSEcCtD
Alendronate—Malaise—Prednisolone—psoriasis	0.000901	0.000943	CcSEcCtD
Alendronate—Discomfort—Mycophenolate mofetil—psoriasis	0.000901	0.000943	CcSEcCtD
Alendronate—Dysgeusia—Triamcinolone—psoriasis	0.0009	0.000941	CcSEcCtD
Alendronate—Vertigo—Prednisolone—psoriasis	0.000898	0.000939	CcSEcCtD
Alendronate—Angioedema—Hydrocortisone—psoriasis	0.000892	0.000933	CcSEcCtD
Alendronate—Infection—Cyclosporine—psoriasis	0.00089	0.000931	CcSEcCtD
Alendronate—Malaise—Hydrocortisone—psoriasis	0.00088	0.000921	CcSEcCtD
Alendronate—Vertigo—Hydrocortisone—psoriasis	0.000877	0.000917	CcSEcCtD
Alendronate—Body temperature increased—Mycophenolic acid—psoriasis	0.000876	0.000916	CcSEcCtD
Alendronate—Abdominal pain—Mycophenolic acid—psoriasis	0.000876	0.000916	CcSEcCtD
Alendronate—Dizziness—Hydroxyurea—psoriasis	0.000875	0.000915	CcSEcCtD
Alendronate—Asthma—Methotrexate—psoriasis	0.000871	0.000911	CcSEcCtD
Alendronate—Infection—Mycophenolate mofetil—psoriasis	0.000869	0.000909	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—ICAM1—psoriasis	0.000863	0.0197	CbGpPWpGaD
Alendronate—Ill-defined disorder—Triamcinolone—psoriasis	0.000853	0.000892	CcSEcCtD
Alendronate—Alopecia—Dexamethasone—psoriasis	0.000846	0.000885	CcSEcCtD
Alendronate—Alopecia—Betamethasone—psoriasis	0.000846	0.000885	CcSEcCtD
Alendronate—Vomiting—Hydroxyurea—psoriasis	0.000841	0.00088	CcSEcCtD
Alendronate—Discomfort—Prednisolone—psoriasis	0.000841	0.000879	CcSEcCtD
Alendronate—Angioedema—Triamcinolone—psoriasis	0.00084	0.000878	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—psoriasis	0.000838	0.000877	CcSEcCtD
Alendronate—Abdominal discomfort—Methotrexate—psoriasis	0.000835	0.000873	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—psoriasis	0.000834	0.000873	CcSEcCtD
Alendronate—Rash—Hydroxyurea—psoriasis	0.000834	0.000872	CcSEcCtD
Alendronate—Erythema—Dexamethasone—psoriasis	0.000834	0.000872	CcSEcCtD
Alendronate—Erythema—Betamethasone—psoriasis	0.000834	0.000872	CcSEcCtD
Alendronate—Dermatitis—Hydroxyurea—psoriasis	0.000833	0.000872	CcSEcCtD
Alendronate—Myalgia—Hydrocortisone—psoriasis	0.000831	0.000869	CcSEcCtD
Alendronate—Malaise—Triamcinolone—psoriasis	0.000829	0.000867	CcSEcCtD
Alendronate—Headache—Hydroxyurea—psoriasis	0.000829	0.000867	CcSEcCtD
Alendronate—Vertigo—Triamcinolone—psoriasis	0.000826	0.000864	CcSEcCtD
Alendronate—Discomfort—Hydrocortisone—psoriasis	0.000821	0.000859	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000817	0.000854	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000797	0.000833	CcSEcCtD
Alendronate—Photosensitivity reaction—Methotrexate—psoriasis	0.000795	0.000832	CcSEcCtD
Alendronate—Asthenia—Mycophenolic acid—psoriasis	0.000795	0.000831	CcSEcCtD
Alendronate—Infection—Hydrocortisone—psoriasis	0.000791	0.000828	CcSEcCtD
Alendronate—Dyspepsia—Cyclosporine—psoriasis	0.000789	0.000825	CcSEcCtD
Alendronate—Nausea—Hydroxyurea—psoriasis	0.000786	0.000822	CcSEcCtD
Alendronate—Pruritus—Mycophenolic acid—psoriasis	0.000784	0.00082	CcSEcCtD
Alendronate—Myalgia—Triamcinolone—psoriasis	0.000782	0.000818	CcSEcCtD
Alendronate—Ill-defined disorder—Betamethasone—psoriasis	0.000774	0.000809	CcSEcCtD
Alendronate—Ill-defined disorder—Dexamethasone—psoriasis	0.000774	0.000809	CcSEcCtD
Alendronate—Discomfort—Triamcinolone—psoriasis	0.000773	0.000809	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00077	0.000805	CcSEcCtD
Alendronate—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00077	0.000805	CcSEcCtD
Alendronate—Pain—Cyclosporine—psoriasis	0.000766	0.000802	CcSEcCtD
Alendronate—Constipation—Cyclosporine—psoriasis	0.000766	0.000802	CcSEcCtD
Alendronate—Angioedema—Betamethasone—psoriasis	0.000762	0.000797	CcSEcCtD
Alendronate—Angioedema—Dexamethasone—psoriasis	0.000762	0.000797	CcSEcCtD
Alendronate—Diarrhoea—Mycophenolic acid—psoriasis	0.000758	0.000793	CcSEcCtD
Alendronate—Stomatitis—Methotrexate—psoriasis	0.000757	0.000792	CcSEcCtD
Alendronate—Malaise—Betamethasone—psoriasis	0.000752	0.000787	CcSEcCtD
Alendronate—Malaise—Dexamethasone—psoriasis	0.000752	0.000787	CcSEcCtD
Alendronate—Vertigo—Dexamethasone—psoriasis	0.000749	0.000784	CcSEcCtD
Alendronate—Vertigo—Betamethasone—psoriasis	0.000749	0.000784	CcSEcCtD
Alendronate—Pain—Mycophenolate mofetil—psoriasis	0.000748	0.000782	CcSEcCtD
Alendronate—Constipation—Mycophenolate mofetil—psoriasis	0.000748	0.000782	CcSEcCtD
Alendronate—Infection—Triamcinolone—psoriasis	0.000745	0.000779	CcSEcCtD
Alendronate—Feeling abnormal—Cyclosporine—psoriasis	0.000739	0.000773	CcSEcCtD
Alendronate—Alopecia—Prednisone—psoriasis	0.000737	0.000771	CcSEcCtD
Alendronate—Gastrointestinal pain—Cyclosporine—psoriasis	0.000733	0.000767	CcSEcCtD
Alendronate—Dizziness—Mycophenolic acid—psoriasis	0.000733	0.000766	CcSEcCtD
Alendronate—Erythema—Prednisone—psoriasis	0.000726	0.00076	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000726	0.000759	CcSEcCtD
Alendronate—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000721	0.000754	CcSEcCtD
Alendronate—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000715	0.000748	CcSEcCtD
Alendronate—Urticaria—Cyclosporine—psoriasis	0.000712	0.000745	CcSEcCtD
Alendronate—Myalgia—Dexamethasone—psoriasis	0.00071	0.000743	CcSEcCtD
Alendronate—Myalgia—Betamethasone—psoriasis	0.00071	0.000743	CcSEcCtD
Alendronate—Body temperature increased—Cyclosporine—psoriasis	0.000709	0.000741	CcSEcCtD
Alendronate—Abdominal pain—Cyclosporine—psoriasis	0.000709	0.000741	CcSEcCtD
Alendronate—Vomiting—Mycophenolic acid—psoriasis	0.000704	0.000737	CcSEcCtD
Alendronate—Discomfort—Dexamethasone—psoriasis	0.000701	0.000734	CcSEcCtD
Alendronate—Discomfort—Betamethasone—psoriasis	0.000701	0.000734	CcSEcCtD
Alendronate—Dyspepsia—Hydrocortisone—psoriasis	0.000701	0.000733	CcSEcCtD
Alendronate—Haemoglobin—Methotrexate—psoriasis	0.000701	0.000733	CcSEcCtD
Alendronate—Rash—Mycophenolic acid—psoriasis	0.000699	0.000731	CcSEcCtD
Alendronate—Dermatitis—Mycophenolic acid—psoriasis	0.000698	0.00073	CcSEcCtD
Alendronate—Pain—Prednisolone—psoriasis	0.000697	0.00073	CcSEcCtD
Alendronate—Haemorrhage—Methotrexate—psoriasis	0.000697	0.000729	CcSEcCtD
Alendronate—Urticaria—Mycophenolate mofetil—psoriasis	0.000695	0.000727	CcSEcCtD
Alendronate—Headache—Mycophenolic acid—psoriasis	0.000694	0.000726	CcSEcCtD
Alendronate—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000691	0.000723	CcSEcCtD
Alendronate—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000691	0.000723	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000683	0.000715	CcSEcCtD
Alendronate—Pain—Hydrocortisone—psoriasis	0.000681	0.000712	CcSEcCtD
Alendronate—Infection—Dexamethasone—psoriasis	0.000676	0.000707	CcSEcCtD
Alendronate—Infection—Betamethasone—psoriasis	0.000676	0.000707	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—psoriasis	0.000674	0.000705	CcSEcCtD
Alendronate—Feeling abnormal—Prednisolone—psoriasis	0.000672	0.000703	CcSEcCtD
Alendronate—Anaemia—Prednisone—psoriasis	0.000671	0.000702	CcSEcCtD
Alendronate—Angioedema—Prednisone—psoriasis	0.000664	0.000694	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—TYK2—psoriasis	0.000661	0.0151	CbGpPWpGaD
Alendronate—Hypersensitivity—Cyclosporine—psoriasis	0.00066	0.000691	CcSEcCtD
Alendronate—Dyspepsia—Triamcinolone—psoriasis	0.00066	0.000691	CcSEcCtD
Alendronate—Erythema multiforme—Methotrexate—psoriasis	0.000659	0.000689	CcSEcCtD
Alendronate—Nausea—Mycophenolic acid—psoriasis	0.000658	0.000688	CcSEcCtD
Alendronate—Feeling abnormal—Hydrocortisone—psoriasis	0.000656	0.000687	CcSEcCtD
Alendronate—Malaise—Prednisone—psoriasis	0.000655	0.000685	CcSEcCtD
Alendronate—Vertigo—Prednisone—psoriasis	0.000652	0.000682	CcSEcCtD
Alendronate—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000651	0.000681	CcSEcCtD
Alendronate—Urticaria—Prednisolone—psoriasis	0.000648	0.000678	CcSEcCtD
Alendronate—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000644	0.000674	CcSEcCtD
Alendronate—Asthenia—Cyclosporine—psoriasis	0.000643	0.000673	CcSEcCtD
Alendronate—Pain—Triamcinolone—psoriasis	0.000641	0.000671	CcSEcCtD
Alendronate—Pruritus—Cyclosporine—psoriasis	0.000634	0.000663	CcSEcCtD
Alendronate—Urticaria—Hydrocortisone—psoriasis	0.000633	0.000662	CcSEcCtD
Alendronate—Body temperature increased—Hydrocortisone—psoriasis	0.00063	0.000659	CcSEcCtD
Alendronate—Abdominal pain—Hydrocortisone—psoriasis	0.00063	0.000659	CcSEcCtD
Alendronate—Asthenia—Mycophenolate mofetil—psoriasis	0.000627	0.000656	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.00062	0.000649	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Betamethasone—psoriasis	0.00062	0.000649	CcSEcCtD
Alendronate—Pruritus—Mycophenolate mofetil—psoriasis	0.000619	0.000647	CcSEcCtD
Alendronate—Myalgia—Prednisone—psoriasis	0.000618	0.000647	CcSEcCtD
Alendronate—Feeling abnormal—Triamcinolone—psoriasis	0.000618	0.000646	CcSEcCtD
Alendronate—Alopecia—Methotrexate—psoriasis	0.000616	0.000644	CcSEcCtD
Alendronate—Diarrhoea—Cyclosporine—psoriasis	0.000613	0.000641	CcSEcCtD
Alendronate—Discomfort—Prednisone—psoriasis	0.000611	0.000639	CcSEcCtD
Alendronate—Erythema—Methotrexate—psoriasis	0.000607	0.000635	CcSEcCtD
Alendronate—Hypersensitivity—Prednisolone—psoriasis	0.000601	0.000629	CcSEcCtD
Alendronate—Dyspepsia—Betamethasone—psoriasis	0.000599	0.000627	CcSEcCtD
Alendronate—Dyspepsia—Dexamethasone—psoriasis	0.000599	0.000627	CcSEcCtD
Alendronate—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000598	0.000626	CcSEcCtD
Alendronate—Urticaria—Triamcinolone—psoriasis	0.000596	0.000623	CcSEcCtD
Alendronate—Dysgeusia—Methotrexate—psoriasis	0.000594	0.000622	CcSEcCtD
Alendronate—Body temperature increased—Triamcinolone—psoriasis	0.000593	0.00062	CcSEcCtD
Alendronate—Dizziness—Cyclosporine—psoriasis	0.000593	0.00062	CcSEcCtD
Alendronate—Infection—Prednisone—psoriasis	0.000589	0.000616	CcSEcCtD
Alendronate—Hypersensitivity—Hydrocortisone—psoriasis	0.000587	0.000614	CcSEcCtD
Alendronate—Pain—Dexamethasone—psoriasis	0.000582	0.000609	CcSEcCtD
Alendronate—Pain—Betamethasone—psoriasis	0.000582	0.000609	CcSEcCtD
Alendronate—Dizziness—Mycophenolate mofetil—psoriasis	0.000578	0.000605	CcSEcCtD
Alendronate—Asthenia—Hydrocortisone—psoriasis	0.000572	0.000598	CcSEcCtD
Alendronate—Vomiting—Cyclosporine—psoriasis	0.00057	0.000596	CcSEcCtD
Alendronate—Rash—Cyclosporine—psoriasis	0.000565	0.000591	CcSEcCtD
Alendronate—Dermatitis—Cyclosporine—psoriasis	0.000565	0.000591	CcSEcCtD
Alendronate—Pruritus—Hydrocortisone—psoriasis	0.000564	0.000589	CcSEcCtD
Alendronate—Ill-defined disorder—Methotrexate—psoriasis	0.000563	0.000589	CcSEcCtD
Alendronate—Headache—Cyclosporine—psoriasis	0.000562	0.000587	CcSEcCtD
Alendronate—Anaemia—Methotrexate—psoriasis	0.000561	0.000587	CcSEcCtD
Alendronate—Feeling abnormal—Dexamethasone—psoriasis	0.000561	0.000587	CcSEcCtD
Alendronate—Feeling abnormal—Betamethasone—psoriasis	0.000561	0.000587	CcSEcCtD
Alendronate—Gastrointestinal pain—Betamethasone—psoriasis	0.000557	0.000582	CcSEcCtD
Alendronate—Gastrointestinal pain—Dexamethasone—psoriasis	0.000557	0.000582	CcSEcCtD
Alendronate—Vomiting—Mycophenolate mofetil—psoriasis	0.000556	0.000581	CcSEcCtD
Alendronate—Hypersensitivity—Triamcinolone—psoriasis	0.000553	0.000578	CcSEcCtD
Alendronate—Rash—Mycophenolate mofetil—psoriasis	0.000551	0.000577	CcSEcCtD
Alendronate—Dermatitis—Mycophenolate mofetil—psoriasis	0.000551	0.000576	CcSEcCtD
Alendronate—Headache—Mycophenolate mofetil—psoriasis	0.000548	0.000573	CcSEcCtD
Alendronate—Malaise—Methotrexate—psoriasis	0.000547	0.000572	CcSEcCtD
Alendronate—Vertigo—Methotrexate—psoriasis	0.000545	0.00057	CcSEcCtD
Alendronate—Diarrhoea—Hydrocortisone—psoriasis	0.000545	0.00057	CcSEcCtD
Alendronate—Urticaria—Betamethasone—psoriasis	0.000541	0.000565	CcSEcCtD
Alendronate—Urticaria—Dexamethasone—psoriasis	0.000541	0.000565	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—psoriasis	0.00054	0.000565	CcSEcCtD
Alendronate—Dizziness—Prednisolone—psoriasis	0.000539	0.000564	CcSEcCtD
Alendronate—Asthenia—Triamcinolone—psoriasis	0.000538	0.000563	CcSEcCtD
Alendronate—Abdominal pain—Dexamethasone—psoriasis	0.000538	0.000563	CcSEcCtD
Alendronate—Body temperature increased—Betamethasone—psoriasis	0.000538	0.000563	CcSEcCtD
Alendronate—Body temperature increased—Dexamethasone—psoriasis	0.000538	0.000563	CcSEcCtD
Alendronate—Abdominal pain—Betamethasone—psoriasis	0.000538	0.000563	CcSEcCtD
Alendronate—Nausea—Cyclosporine—psoriasis	0.000532	0.000557	CcSEcCtD
Alendronate—Pruritus—Triamcinolone—psoriasis	0.000531	0.000555	CcSEcCtD
Alendronate—Dizziness—Hydrocortisone—psoriasis	0.000527	0.000551	CcSEcCtD
Alendronate—Dyspepsia—Prednisone—psoriasis	0.000522	0.000546	CcSEcCtD
Alendronate—Nausea—Mycophenolate mofetil—psoriasis	0.000519	0.000543	CcSEcCtD
Alendronate—Myalgia—Methotrexate—psoriasis	0.000517	0.00054	CcSEcCtD
Alendronate—Chest pain—Methotrexate—psoriasis	0.000517	0.00054	CcSEcCtD
Alendronate—Rash—Prednisolone—psoriasis	0.000514	0.000538	CcSEcCtD
Alendronate—Dermatitis—Prednisolone—psoriasis	0.000514	0.000537	CcSEcCtD
Alendronate—Headache—Prednisolone—psoriasis	0.000511	0.000534	CcSEcCtD
Alendronate—Discomfort—Methotrexate—psoriasis	0.000511	0.000534	CcSEcCtD
Alendronate—Constipation—Prednisone—psoriasis	0.000507	0.00053	CcSEcCtD
Alendronate—Vomiting—Hydrocortisone—psoriasis	0.000506	0.00053	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CP—psoriasis	0.000506	0.0115	CbGpPWpGaD
Alendronate—Rash—Hydrocortisone—psoriasis	0.000502	0.000525	CcSEcCtD
Alendronate—Dermatitis—Hydrocortisone—psoriasis	0.000502	0.000525	CcSEcCtD
Alendronate—Headache—Hydrocortisone—psoriasis	0.000499	0.000522	CcSEcCtD
Alendronate—Dizziness—Triamcinolone—psoriasis	0.000496	0.000519	CcSEcCtD
Alendronate—Infection—Methotrexate—psoriasis	0.000492	0.000515	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—psoriasis	0.000488	0.000511	CcSEcCtD
Alendronate—Asthenia—Dexamethasone—psoriasis	0.000488	0.000511	CcSEcCtD
Alendronate—Asthenia—Betamethasone—psoriasis	0.000488	0.000511	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—psoriasis	0.000485	0.000507	CcSEcCtD
Alendronate—Nausea—Prednisolone—psoriasis	0.000484	0.000507	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CARM1—psoriasis	0.000483	0.011	CbGpPWpGaD
Alendronate—Pruritus—Betamethasone—psoriasis	0.000482	0.000504	CcSEcCtD
Alendronate—Pruritus—Dexamethasone—psoriasis	0.000482	0.000504	CcSEcCtD
Alendronate—Vomiting—Triamcinolone—psoriasis	0.000477	0.000499	CcSEcCtD
Alendronate—Nausea—Hydrocortisone—psoriasis	0.000473	0.000495	CcSEcCtD
Alendronate—Rash—Triamcinolone—psoriasis	0.000473	0.000495	CcSEcCtD
Alendronate—Dermatitis—Triamcinolone—psoriasis	0.000472	0.000494	CcSEcCtD
Alendronate—Urticaria—Prednisone—psoriasis	0.000471	0.000492	CcSEcCtD
Alendronate—Headache—Triamcinolone—psoriasis	0.00047	0.000491	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—psoriasis	0.000469	0.00049	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—psoriasis	0.000469	0.00049	CcSEcCtD
Alendronate—Diarrhoea—Dexamethasone—psoriasis	0.000466	0.000487	CcSEcCtD
Alendronate—Diarrhoea—Betamethasone—psoriasis	0.000466	0.000487	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000451	0.000472	CcSEcCtD
Alendronate—Dizziness—Betamethasone—psoriasis	0.00045	0.000471	CcSEcCtD
Alendronate—Dizziness—Dexamethasone—psoriasis	0.00045	0.000471	CcSEcCtD
Alendronate—Nausea—Triamcinolone—psoriasis	0.000446	0.000466	CcSEcCtD
Alendronate—Hypersensitivity—Prednisone—psoriasis	0.000437	0.000457	CcSEcCtD
Alendronate—Dyspepsia—Methotrexate—psoriasis	0.000436	0.000456	CcSEcCtD
Alendronate—FDPS—Metabolism—NDUFA5—psoriasis	0.000436	0.00992	CbGpPWpGaD
Alendronate—Vomiting—Dexamethasone—psoriasis	0.000433	0.000453	CcSEcCtD
Alendronate—Vomiting—Betamethasone—psoriasis	0.000433	0.000453	CcSEcCtD
Alendronate—Rash—Dexamethasone—psoriasis	0.000429	0.000449	CcSEcCtD
Alendronate—Rash—Betamethasone—psoriasis	0.000429	0.000449	CcSEcCtD
Alendronate—Dermatitis—Dexamethasone—psoriasis	0.000429	0.000448	CcSEcCtD
Alendronate—Dermatitis—Betamethasone—psoriasis	0.000429	0.000448	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HCAR2—psoriasis	0.000428	0.00976	CbGpPWpGaD
Alendronate—Headache—Betamethasone—psoriasis	0.000426	0.000446	CcSEcCtD
Alendronate—Headache—Dexamethasone—psoriasis	0.000426	0.000446	CcSEcCtD
Alendronate—Asthenia—Prednisone—psoriasis	0.000425	0.000445	CcSEcCtD
Alendronate—Pain—Methotrexate—psoriasis	0.000424	0.000443	CcSEcCtD
Alendronate—Pruritus—Prednisone—psoriasis	0.000419	0.000439	CcSEcCtD
Alendronate—Feeling abnormal—Methotrexate—psoriasis	0.000408	0.000427	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000406	0.00925	CbGpPWpGaD
Alendronate—Diarrhoea—Prednisone—psoriasis	0.000406	0.000424	CcSEcCtD
Alendronate—Gastrointestinal pain—Methotrexate—psoriasis	0.000405	0.000424	CcSEcCtD
Alendronate—Nausea—Dexamethasone—psoriasis	0.000404	0.000423	CcSEcCtD
Alendronate—Nausea—Betamethasone—psoriasis	0.000404	0.000423	CcSEcCtD
Alendronate—Urticaria—Methotrexate—psoriasis	0.000394	0.000412	CcSEcCtD
Alendronate—Dizziness—Prednisone—psoriasis	0.000392	0.00041	CcSEcCtD
Alendronate—Body temperature increased—Methotrexate—psoriasis	0.000392	0.00041	CcSEcCtD
Alendronate—Abdominal pain—Methotrexate—psoriasis	0.000392	0.00041	CcSEcCtD
Alendronate—Vomiting—Prednisone—psoriasis	0.000377	0.000394	CcSEcCtD
Alendronate—Rash—Prednisone—psoriasis	0.000374	0.000391	CcSEcCtD
Alendronate—Dermatitis—Prednisone—psoriasis	0.000373	0.000391	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—TAGAP—psoriasis	0.000371	0.00846	CbGpPWpGaD
Alendronate—Headache—Prednisone—psoriasis	0.000371	0.000388	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP2S1—psoriasis	0.00037	0.00843	CbGpPWpGaD
Alendronate—Hypersensitivity—Methotrexate—psoriasis	0.000365	0.000382	CcSEcCtD
Alendronate—Asthenia—Methotrexate—psoriasis	0.000355	0.000372	CcSEcCtD
Alendronate—Nausea—Prednisone—psoriasis	0.000352	0.000368	CcSEcCtD
Alendronate—Pruritus—Methotrexate—psoriasis	0.00035	0.000367	CcSEcCtD
Alendronate—Diarrhoea—Methotrexate—psoriasis	0.000339	0.000354	CcSEcCtD
Alendronate—Dizziness—Methotrexate—psoriasis	0.000328	0.000343	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—psoriasis	0.000323	0.00737	CbGpPWpGaD
Alendronate—Vomiting—Methotrexate—psoriasis	0.000315	0.000329	CcSEcCtD
Alendronate—Rash—Methotrexate—psoriasis	0.000312	0.000327	CcSEcCtD
Alendronate—Dermatitis—Methotrexate—psoriasis	0.000312	0.000326	CcSEcCtD
Alendronate—Headache—Methotrexate—psoriasis	0.00031	0.000325	CcSEcCtD
Alendronate—Nausea—Methotrexate—psoriasis	0.000294	0.000308	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CCL20—psoriasis	0.000222	0.00507	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000194	0.00442	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CARM1—psoriasis	0.000181	0.00412	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—psoriasis	0.000169	0.00385	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HLA-A—psoriasis	0.000138	0.00315	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—psoriasis	0.000129	0.00294	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SOCS1—psoriasis	0.000123	0.00279	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—psoriasis	0.00012	0.00274	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAT—psoriasis	0.000111	0.00253	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TYK2—psoriasis	9.85e-05	0.00224	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—psoriasis	9.04e-05	0.00206	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—psoriasis	9.04e-05	0.00206	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CD4—psoriasis	8.91e-05	0.00203	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—psoriasis	8.64e-05	0.00197	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKBIA—psoriasis	8.43e-05	0.00192	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—psoriasis	7.53e-05	0.00171	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TYK2—psoriasis	6.9e-05	0.00157	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—psoriasis	6.9e-05	0.00157	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—psoriasis	6.01e-05	0.00137	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—psoriasis	5.59e-05	0.00127	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKB1—psoriasis	5.38e-05	0.00122	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—psoriasis	4.88e-05	0.00111	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—psoriasis	4.83e-05	0.0011	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—psoriasis	4.82e-05	0.0011	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—psoriasis	3.69e-05	0.00084	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—psoriasis	3.38e-05	0.000769	CbGpPWpGaD
